N/A
Completed N=61
Increasing Adherence to Treatment Recommendations Following a Cardiac Event
Source: ClinicalTrials.gov NCT02327260 ↗Enrolled (actual)
61
Serious AEs
—
Results posted
Apr 2019
Primary outcomePrimary: Participation in CR — 7; 11; 6 Participants
Summary
This project will pilot test an intervention to increase participation rates in cardiac rehabilitation and medication adherence among patients following a cardiovascular event. The intervention will use an educational video shown during referral to cardiac rehabilitation (before hospital discharge), along with a brief, telephone-delivered counseling session to increase motivation to participate in cardiac rehabilitation and take all cardiac medications as prescribed (following hospital discharge). One hundred twenty patients who have experienced a cardiovascular event, and who are eligible for cardiac rehabilitation, will be recruited to participate in the study. Three groups of participants (40 each) will be formed: a control group that receives standard care, a first experimental group that sees the educational video and receives motivational counseling to attend cardiac rehabilitation, and a second experimental group that receives motivational counseling to adhere to their medications as prescribed. It is expected that the experimental group participants will differ from the control group participants in rates of participation in cardiac rehabilitation (experimental group #1) and medication adherence (experimental group #2). If successful, this intervention could be used in hospital settings to increase patients' adherence behaviors.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Participation in CR |
7; 11; 6 | — |
| PRIMARY Adherence (Ratio): P2Y12 Platelet Inhibitor |
.47; .72; .46 | — |
| PRIMARY Adherence (Ratio): Beta-Blocker |
.20; .39; .40 | — |
| PRIMARY Adherence (Ratio): Statin |
.22; .37; .46 | — |
| PRIMARY Adherence (Ratio): Angiotensin System Blocker |
.26; .44; .91 | — |
| PRIMARY Number of Participants With Self-reported Medication Adherence: P2Y12 Platelet Inhibitor |
9; 5; 7 | — |
| PRIMARY Number of Participants With Self-reported Medication Adherence: Beta-Blocker |
10; 8; 8 | — |
| PRIMARY Number of Participants With Self-reported Medication Adherence: Statin |
10; 9; 12 | — |
| PRIMARY Number of Participants With Self-reported Medication Adherence: Angiotensin System Blocker |
11; 11; 7 | — |
Eligibility Criteria
Inclusion Criteria
- Referral to CR according to the AACVPR/ACCF/AHA guidelines
- English speaking
- At least 18 years of age
- Lack of physical or cognitive impairments that would limit patients' abilities to complete study materials or participate in CR.
Exclusion Criteria
- Physical impairment such as debilitating stroke or another medical condition that would limit their ability to complete the study materials or participate in CR
- Patients transferred to an outside facility for revascularization procedures
- Previous participation in this research protocol (i.e. patients can only participate one time)
- Non-English speaking.
Data sourced from ClinicalTrials.gov (NCT02327260). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.